The FibreGum study – Changing the course of obesity
The goal of our study is to increase weight reduction in obese children and adolescents by stimulating the gut microbiome with a chewing-gum containing dietary fibres as an adjunct treatment to standard adiposity therapy.
Around one in six children in Switzerland is affected by overweight or obesity and the prevalence continues to rise. This increase in obesity and its associated comorbidities represents a huge socio-economic burden, as it leads to increased morbidity and mortality. Obesity is not only a chronic disease in itself, but also a major risk factor for the development of the world’s leading causes of poor health and early death; namely cardiovascular disease, various cancers, diabetes and osteoarthritis.
Read more about the project here.
More recent news
DCB Newsletter #5/26: DID YOU KNOW… CGM data could reveal more than glucose levels?
Dear DCB Community, Continuous glucose monitoring (CGM) has changed the way people manage diabetes. Glucose readings,...
DCB Newsletter #4/26: DID YOU KNOW… that the menstrual cycle can affect diabetes management every month?
Dear DCB Community, We often talk about diabetes management in terms of glucose levels, insulin dosing, carbohydrates,...
DCB Newsletter #3/26: DID YOU KNOW… why type 1 diabetes is rising and what projections to 2050 tell us?
Dear Community, We are happy to provide you with a new episode of our “DID YOU KNOW…” series – this time with a focus...
DCB Research AG
Freiburgstrasse 3
3010 Bern
Schweiz